JP2003516957A - 特に粘膜塗布用の溶液又は懸濁状の有効成分を入れるためのゲル形状組成物及び製造方法 - Google Patents

特に粘膜塗布用の溶液又は懸濁状の有効成分を入れるためのゲル形状組成物及び製造方法

Info

Publication number
JP2003516957A
JP2003516957A JP2001544659A JP2001544659A JP2003516957A JP 2003516957 A JP2003516957 A JP 2003516957A JP 2001544659 A JP2001544659 A JP 2001544659A JP 2001544659 A JP2001544659 A JP 2001544659A JP 2003516957 A JP2003516957 A JP 2003516957A
Authority
JP
Japan
Prior art keywords
composition according
active ingredient
product
composition
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001544659A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003516957A5 (cg-RX-API-DMAC7.html
Inventor
オーゼリー.ジャック
Original Assignee
インベスティゲーションズ.セラピティケス.エサイス.クリニケス.サービス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インベスティゲーションズ.セラピティケス.エサイス.クリニケス.サービス filed Critical インベスティゲーションズ.セラピティケス.エサイス.クリニケス.サービス
Publication of JP2003516957A publication Critical patent/JP2003516957A/ja
Publication of JP2003516957A5 publication Critical patent/JP2003516957A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Detergent Compositions (AREA)
JP2001544659A 1999-12-14 2000-12-14 特に粘膜塗布用の溶液又は懸濁状の有効成分を入れるためのゲル形状組成物及び製造方法 Pending JP2003516957A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/15763 1999-12-14
FR9915763A FR2802097B1 (fr) 1999-12-14 1999-12-14 Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
PCT/FR2000/003533 WO2001043720A1 (fr) 1999-12-14 2000-12-14 Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication

Publications (2)

Publication Number Publication Date
JP2003516957A true JP2003516957A (ja) 2003-05-20
JP2003516957A5 JP2003516957A5 (cg-RX-API-DMAC7.html) 2008-01-31

Family

ID=9553244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001544659A Pending JP2003516957A (ja) 1999-12-14 2000-12-14 特に粘膜塗布用の溶液又は懸濁状の有効成分を入れるためのゲル形状組成物及び製造方法

Country Status (13)

Country Link
US (1) US20030091642A1 (cg-RX-API-DMAC7.html)
EP (1) EP1237537B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003516957A (cg-RX-API-DMAC7.html)
AT (1) ATE336987T1 (cg-RX-API-DMAC7.html)
AU (1) AU2525601A (cg-RX-API-DMAC7.html)
CA (1) CA2394416A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106249T1 (cg-RX-API-DMAC7.html)
DE (1) DE60030319T2 (cg-RX-API-DMAC7.html)
DK (1) DK1237537T3 (cg-RX-API-DMAC7.html)
ES (1) ES2270895T3 (cg-RX-API-DMAC7.html)
FR (1) FR2802097B1 (cg-RX-API-DMAC7.html)
PT (1) PT1237537E (cg-RX-API-DMAC7.html)
WO (1) WO2001043720A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7210833B2 (ja) 2012-07-31 2023-01-24 エギシュ ヂョヂセルヂャール ザートケルエン ミケデ レースヴェーニタールササーグ Cox阻害薬を含有する経皮製剤

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2005027807A1 (en) 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
CA2605341A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
WO2007079389A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05262670A (ja) * 1991-12-19 1993-10-12 Lek Tovarna Farmacevtskih 熱可逆性ゲル、液状ガレン製剤及びその製造方法
JPH07309763A (ja) * 1993-12-31 1995-11-28 Lab Cusi Sa クロベタゾンおよびトブラマイシンを含有する医薬製剤とその応用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
JP2533723B2 (ja) * 1992-12-28 1996-09-11 東興薬品工業株式会社 速乾性ゲルタイプ手指消毒剤
US5902110A (en) * 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5869601A (en) * 1996-04-05 1999-02-09 S. C. Johnson & Son, Inc. Method of stabilizing the viscosity of a thickened composition
AU7472398A (en) * 1997-05-09 1998-11-27 Medlogic Global Corporation Compositions for cosmetic applications
US7064114B2 (en) * 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05262670A (ja) * 1991-12-19 1993-10-12 Lek Tovarna Farmacevtskih 熱可逆性ゲル、液状ガレン製剤及びその製造方法
JPH07309763A (ja) * 1993-12-31 1995-11-28 Lab Cusi Sa クロベタゾンおよびトブラマイシンを含有する医薬製剤とその応用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7210833B2 (ja) 2012-07-31 2023-01-24 エギシュ ヂョヂセルヂャール ザートケルエン ミケデ レースヴェーニタールササーグ Cox阻害薬を含有する経皮製剤

Also Published As

Publication number Publication date
DK1237537T3 (da) 2006-12-27
EP1237537A1 (fr) 2002-09-11
FR2802097A1 (fr) 2001-06-15
PT1237537E (pt) 2007-01-31
ATE336987T1 (de) 2006-09-15
US20030091642A1 (en) 2003-05-15
CY1106249T1 (el) 2011-06-08
FR2802097B1 (fr) 2002-12-13
AU2525601A (en) 2001-06-25
DE60030319T2 (de) 2007-08-30
DE60030319D1 (de) 2006-10-05
ES2270895T3 (es) 2007-04-16
EP1237537B1 (fr) 2006-08-23
WO2001043720A1 (fr) 2001-06-21
CA2394416A1 (fr) 2001-06-21

Similar Documents

Publication Publication Date Title
ES2308045T3 (es) Composiciones fungicidas, lubricantes de calentamiento y no irritantes en la forma de un gel.
JP6473103B2 (ja) 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
US6824762B2 (en) Nasal spray compositions
AU2018220020C1 (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site.
EP0101178B2 (en) Topical anti-inflammatory compositions
US20120308648A1 (en) Methods of treating hot flashes with formulations for transdermal or transmucosal application
JP2017517577A (ja) 特定の投薬量の活性物質を皮膚又は粘膜に投与するための電気流体力学的に得られた繊維を含む組成物
JP2002514220A (ja) 熱傷処置および感染防止のための局部スプレー
JP2001508038A (ja) 粘膜表面および身体組織に付与可能な薬学的ゲル調製物
JP3545162B2 (ja) 口腔用組成物
KR20050025166A (ko) 가온성 및 무자극성 윤활제 항진균성 겔 조성물
JPH08188527A (ja) シート状パック剤
WO2001043735A1 (en) Nitroglycerin ointment for treatment of pain associated with anal disease
JPH10503194A (ja) 多くの異なる活性成分を含有する医薬組成物、主として腟座薬
JP4575632B2 (ja) 片頭痛緩和用薬剤
JPWO2001043736A1 (ja) 片頭痛緩和用薬剤
US20030091642A1 (en) Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
JP2003055193A (ja) 清涼化剤含有ゲル状外用剤
JP3157082B2 (ja) 医療用パック型製剤用基剤および医療用パック型製剤
JPS6251626A (ja) 外用ゲル組成物
WO2019008472A1 (en) PHARMACEUTICAL COMPOSITIONS OF LIGNOCAINE HCL
CN107638384A (zh) 经皮递送生理活性物质的水性体系及其技术
JPS6044344B2 (ja) 外用アルコ−ルゲル組成物
HK1132453A (en) Methods of treating hot flashes with formulations for transdermal or transmucosal application

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20061101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071203

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071203

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20100423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110209

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110428

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110511

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110729